Paksoy provides advice across a broad spectrum of areas including pharmaceuticals, biotechnology, medical devices, nutritional supplements, clinical research and private hospitals.
We assist our clients on a wide range of issues concerning the healthcare and life sciences sector. We provide guidance from product inception to final marketing and commercialisation of products in Turkey.
We also support our clients in drafting contracts regarding manufacturing and distribution of medical devices and medicinal products, devising and implementing compliance programs, in particular with regard to the promotion, transparency rules and public procurement legislation.
We also have substantial experience of the issues affecting healthcare and life sciences companies in the context of M&A transactions.
“ Paksoy is one of the few Turkish firms to gain recognition in this specialist area. ”
PLC Which Lawyer
Featured publications
27 October 2020
Manufacturing of medicinal products for human use in Turkey
Our latest article "Manufacturing of medicinal products for human use in Turkey" is published on Lexology.
Related contents
4 September 2025
Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher
Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…
21 July 2025
Recent Developments in Healthcare Legislation – Q2 2025
Amendment to the Regulation on the Clinical Trials of Medicinal Products for Human Use. On 5 June 2025, the Regulation on Clinical Trials…
2 June 2025
Pricing of Medicinal Products for Human Use in Türkiye
Pricing of medicinal products in Türkiye is governed by a comprehensive regulatory framework that imposes specific obligations on…
29 April 2025
Regulation on Private Health Institutions Providing Outpatient Diagnosis and Treatment
The Regulation on Private Health Institutions Providing Outpatient Diagnosis and Treatment Services (“Regulation“) was published in the…
24 March 2025
Recent Developments in Healthcare Legislation – Winter Issue 2025
Amendment to the Regulation on the Licensing of Medicinal Products for Human Use. An amendment to the Regulation on the Licensing of…
6 February 2025
Developments in Private Hospitals Legislation
Following the entry into force of the Regulation on Private Hospitals (“Regulation“) published in the Official Gazette on 30 January 2025,…